| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000262202.3 |
ABT-263 (navitoclax) |
Sarcoma |
0.022052865 |
Resistant |
| ENSG00000262202.3 |
ABT-263 (navitoclax) |
Bladder urothelial carcinoma |
0.036866317 |
Sensitive |
| ENSG00000262202.3 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.04315844 |
Sensitive |
